REGULATED PRESS RELEASE published on 11/12/2025 at 15:26, 5 months 11 days ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2025 Safran's monthly statement reveals 423,632,587 shares comprising the share capital with 537,686,984 theoretical voting rights and 531,749,457 exercisable rights Safran Share Capital Voting Rights French Commercial Code Monthly Statement
BRIEF published on 11/12/2025 at 11:44, 5 months 11 days ago Safran Announces Share Buyback Transactions Safran Euronext Paris Share Buyback Market Abuse Regulation Banco Santander
REGULATED PRESS RELEASE published on 11/12/2025 at 11:39, 5 months 11 days ago Statement of transactions in own shares from November 3, 2025 to November 7, 2025 SAFRAN purchased own shares totaling 30,000 with a daily weighted average purchase price of 302.73 EUR from November 3 to November 7, 2025 through Banco Santander S.A Safran Shares Purchase 2025 Banco Santander
BRIEF published on 11/06/2025 at 18:24, 5 months 16 days ago Safran Reports Share Repurchase Activity for Late October 2025 Safran Share Buyback XPAR Market October 2025 Banco Santander
REGULATED PRESS RELEASE published on 11/06/2025 at 18:19, 5 months 16 days ago Statement of transactions in own shares from October 27, 2025 to October 31, 2025 SAFRAN's own shares purchases data from October 27 to October 31, 2025, including total daily volume and daily weighted average purchase price per share Safran Own Shares Purchases 2025 October 27-31
BRIEF published on 10/27/2025 at 17:43, 5 months 26 days ago Safran Reveals Share Buyback Transactions for Late October 2025 Safran Share Buyback XPAR October 2025 Banco Santander
REGULATED PRESS RELEASE published on 10/27/2025 at 17:38, 5 months 26 days ago Statement of transactions in own shares from October 20, 2025 to October 24, 2025 SAFRAN: Own shares purchased from Oct 20-24, 2025. Total volume 10,582 shares, average price 306.022756. Details of buyback transactions Safran Transactions Shares Purchase Volume
BRIEF published on 10/24/2025 at 07:05, 5 months 30 days ago Safran's Strong Q3 Performance and Raised 2025 Outlook 2025 Financial Outlook Safran Revenue Growth Civil Engine Aftermarket LEAP Engine Deliveries Acquisitions Integration
REGULATED PRESS RELEASE published on 10/24/2025 at 07:00, 5 months 30 days ago Safran reports third quarter 2025 revenue Safran reports strong Q3 2025 revenue growth of 18.3% reaching €7,852 million. FY guidance raised with solid organic growth in civil engines aftermarket and record LEAP output Safran FY Guidance Q3 2025 Revenue Civil Engines Aftermarket LEAP Output
BRIEF published on 10/20/2025 at 18:27, 6 months 2 days ago Safran Executes Share Buyback Program Safran Share Buyback Stock Market Financial Strategy Banco Santander
Published on 04/23/2026 at 15:00, 37 minutes ago Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 14:00, 1 hour 37 minutes ago Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 14:00, 1 hour 37 minutes ago PPX Mining Provides Exploration Plan for 2026
Published on 04/23/2026 at 15:17, 20 minutes ago EQS-Adhoc: Gateway Real Estate AG is postponing the publication of its 2025 consolidated financial statements
Published on 04/23/2026 at 15:07, 29 minutes ago Resolutions of the 82nd Annual General Meeting of Lenzing Group
Published on 04/23/2026 at 15:00, 37 minutes ago Medartis shareholders endorse Board proposals with strong support at AGM 2026
Published on 04/23/2026 at 14:05, 1 hour 32 minutes ago FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
Published on 04/23/2026 at 14:30, 1 hour 7 minutes ago KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV
Published on 04/23/2026 at 08:00, 7 hours 37 minutes ago Mersen Signs A Contract with Vulcan Energy as part of Europe’s Battery industry initiative
Published on 04/23/2026 at 07:00, 8 hours 37 minutes ago bioMérieux – First-Quarter 2026 Business Review
Published on 04/23/2026 at 07:00, 8 hours 37 minutes ago Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond
